Capricor Therapeutics Faces Financial Challenges Amid Biotech Innovation Efforts
Capricor Therapeutics Inc, a biotech company focused on treating Duchenne Muscular Dystrophy and rare disorders, faces financial turbulence and regulatory challenges, raising questions about the sustainability of its business model.
3 minutes to read